MCKMcKesson Corporation

$115B

Q1 2022 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$62.7B+12.6% YoY

Gross Profit

$2.9B4.6% margin

Operating Income

$800M1.3% margin

Net Income

$486M0.8% margin

EPS (Diluted)

$3.07

QoQ Revenue Growth

+6.0%

Cash Flow

Operating Cash Flow

-$1.6B

Free Cash Flow

-$1.8B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$62.9B

Total Liabilities

$62.9B

Stockholders' Equity

-$529M

Cash & Equivalents

$2.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$62.7B	$55.7B	+12.6%
Gross Profit	$2.9B	$2.6B	+13.1%
Operating Income	$800M	$646M	+23.8%
Net Income	$486M	$444M	+9.5%

Revenue Segments

U.S. Pharmaceutical Segment

$50.0B80%

International Segment

$9.2B15%

Medical-Surgical Solutions Segment

$2.5B4%

Prescription Technology Solutions

$881M1%

MCK Q1 2022 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena